goal_code	goal_labelEN	goal_descEN	target_code	target_descEN	indicator_code	indicator_reference	indicator_descEN	series_release	series_tags	series	seriesDescription	geoAreaCode	geoAreaName	level	parentCode	parentName	type	X	Y	ISO3	UN_Member	Country_Profile	timeCoverage	geoInfoUrl	years	min_year	max_year	n_years	unitsCode	unitsDesc	reportingTypeCode	reportingTypeDesc	value_2000	value_2001	value_2002	value_2003	value_2004	value_2005	value_2006	value_2007	value_2008	value_2009	value_2010	value_2011	value_2012	value_2013	value_2014	value_2015	value_2016	value_2017	value_2018	latest_value	basePeriod	valueDetails	footnotes	sources	timeDetails	nature
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	104	Myanmar	4	35	South-Eastern Asia	Country	96.51752295	21.19332882	MMR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	7.95777	8.82738	8.51847	16.46598	10.21822	13.68841	14.58677	25.2966	34.42241	49.30622	63.45777	39.92489	96.48452	119.25633	149.54397	98.90021	154.83215	123.10503	106.35941	106.35941	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	108	Burundi	5	14	Eastern Africa	Country	29.89080992	-3.366387428	BDI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	3.76854	3.33385	3.66382	5.82018	8.83886	15.48729	15.56805	24.71527	37.88596	29.38018	49.9085	45.6704	39.41335	53.47991	44.89269	53.03543	108.46166	99.3295	101.08858	101.08858	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	11	Western Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	143.46766	265.36167	168.42942	212.35919	327.3609	341.22375	476.36591	504.63263	705.24912	1055.79454	950.18157	869.86961	1087.04758	1331.46313	1498.48097	1999.41607	1722.05942	1772.94231	1556.99901	1556.99901	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	112	Belarus	4	151	Eastern Europe	Country	28.04940161	53.54193075	BLR	1	1			[2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2005	2018	14	CON_USD	Constant USD	G	Global						1.04152	1.08196	2.69102	5.63415	1.04738	10.10669	5.32508	6.38364	5.62167	5.70307	1.31902	6.08458	3.17329	3.84331	3.84331	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	116	Cambodia	4	35	South-Eastern Asia	Country	104.922836	12.71163737	KHM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	18.86826	25.11239	11.54211	23.55532	13.98319	44.9491	41.06182	50.53777	47.57141	61.46992	104.40502	54.21624	56.15739	67.51803	64.52716	74.51923	49.91956	79.44474	60.54723	60.54723	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	12	Algeria	4	15	Northern Africa	Country	2.678164227	28.15940032	DZA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.5998	1.34259	0.7338	0.55224	0.4978	0.66953	0.42885	1.93954	0.30484	0.33741	1.56117	2.83219	0.47868	0.28645	0.17286	0.32032	0.7851	0.4428	0.28927	0.28927	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	120	Cameroon	5	17	Middle Africa	Country	12.7419827	5.692387031	CMR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	24.05503	4.17843	6.71456	8.79988	20.72445	24.80536	29.09876	23.0883	25.51332	35.06176	24.90846	95.29593	42.22466	69.85543	70.72797	100.42746	55.19045	61.57963	73.10782	73.10782	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	127	Southern Asia (excluding India)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	157.22178	150.25738	115.13464	134.57462	196.04303	321.51883	470.59942	538.12322	573.96171	640.06291	782.62656	515.00335	668.86552	919.79035	718.50248	770.69846	862.3014	967.26107	908.58363	908.58363	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	13	Central America	4	419	Latin America and the Caribbean	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	39.06482	49.97206	45.99969	51.9922	49.15491	83.11614	91.8741	103.04013	102.33589	88.67373	85.92924	80.48081	87.12869	77.31842	84.28607	119.11729	86.34823	87.4091	69.61655	69.61655	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	132	Cabo Verde	5	11	Western Africa	Country	-23.63544151	15.07791834	CPV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.25029	4.50431	0.32896	0.2298	1.60921	0.99211	0.47319	0.15589	0.31656	0.59577	1.56346	3.34807	5.60642	3.39112	1.83737	2.66881	0.52959	1.70742	4.87554	4.87554	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	135	Caucasus and Central Asia	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	42.39915	38.31394	52.64806	48.80888	60.1117	60.27491	68.16771	89.37534	94.42427	104.45027	137.71137	131.24325	118.16251	108.93073	121.98439	94.40664	152.3524	144.36184	113.638	113.638	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	14	Eastern Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	423.32242	436.87125	358.63094	440.84019	477.47082	583.73617	782.92869	921.02408	1007.23402	1179.32531	1335.04769	1545.72756	1929.9283	2377.75088	2049.77183	2311.12808	2316.01561	2666.18172	2315.17327	2315.17327	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	140	Central African Republic	5	17	Middle Africa	Country	20.93559492	7.003720791	CAF	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	1.30796	6.82238	8.39127	3.86826	12.00742	8.80986	7.72256	6.25354	11.4911	6.18084	9.80956	9.58913	16.10664	20.14883	38.09835	24.55247	52.31901	51.00054	39.76465	39.76465	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	142	Asia	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	872.23742	535.99118	678.06694	694.4847	810.55073	1610.16771	1726.23919	1703.99748	1533.01	1698.17414	2136.67304	1678.2166	1966.20081	2340.84771	1991.64013	2199.55344	2494.86851	3194.68381	2293.75182	2293.75182	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	143	Central Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	21.48622	27.45311	41.38747	40.88044	54.0125	43.60957	48.6636	50.21871	63.82386	72.27618	95.00643	88.88297	98.24932	79.65757	100.61294	78.90914	123.4556	120.88129	98.01086	98.01086	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	144	Sri Lanka	4	34	Southern Asia	Country	80.70489654	7.614693343	LKA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	6.43653	15.16173	2.86683	6.92763	10.58063	11.50969	10.56273	11.99648	18.06806	20.58093	30.86896	16.12018	20.73224	18.18988	23.40707	35.51905	21.54273	51.13291	27.3099	27.3099	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	145	Western Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	98.94419	42.28562	55.2724	92.09262	159.70635	661.20096	560.78944	402.86989	242.71154	263.56208	281.58288	219.4618	219.39468	244.91621	294.58387	286.03193	323.03058	783.746	452.70006	452.70006	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	148	Chad	5	17	Middle Africa	Country	18.66618401	15.36279341	TCD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	31.85199	4.44146	7.48312	7.57407	13.68206	13.34188	8.03947	11.79588	15.3672	15.58525	41.71742	21.03353	26.56185	61.60233	45.0022	23.71974	64.03396	37.86123	50.40184	50.40184	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	15	Northern Africa	3	2	Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	65.63643	52.92277	65.71549	38.17966	59.57256	120.08055	106.70729	163.76539	184.55618	117.92588	169.76144	127.37489	136.80959	143.21641	111.60878	138.92914	236.14422	128.88735	169.9423	169.9423	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	150	Europe	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	45.11861	31.66764	19.25942	25.86257	18.04334	42.79939	60.84901	53.68836	53.67117	36.97621	49.27618	65.98455	64.87217	63.18509	66.92937	77.36639	133.22987	117.95534	86.25092	86.25092	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	151	Eastern Europe	3	150	Europe	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	10.38989	1.33394	1.31522	1.04973	1.86093	12.43806	19.25349	20.95798	28.93454	28.28444	32.30018	49.92462	53.34806	51.87971	50.9136	67.18356	89.86028	51.7316	63.06628	63.06628	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	152	Chile	5	5	South America	Country	-71.23029019	-35.2652885	CHL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.11315	0.09334	0.3333	0.22318	2.01238	2.3317	0.56077	0.2912	0.29643	0.63466	1.12291	0.7856	0.71841	0.37728	0.43423	0.36787	0.20932	0.66072		0.66072	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	156	China	4	30	Eastern Asia	Country	104.1403375	32.30955217	CHN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	41.07987	35.84979	47.90726	61.60977	58.18188	53.60023	58.60296	107.39177	61.66824	110.43898	123.67842	76.66841	122.83926	96.55034	76.45232	86.14905	174.84168	149.63296	86.37678	86.37678	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	17	Middle Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	120.40333	127.88829	99.15566	101.99273	138.01777	184.60505	180.93116	220.10412	386.13013	384.96796	447.00412	514.79705	543.98695	653.147	651.67691	759.6103	678.24815	685.70658	660.98468	660.98468	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	170	Colombia	5	5	South America	Country	-73.07446751	3.888209046	COL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	3.56295	1.06352	1.16423	0.44866	2.02461	1.3185	1.5247	1.55381	4.66956	3.57858	17.24048	14.52365	5.94406	11.05131	9.34143	4.68099	3.40437	11.14549	4.52468	4.52468	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	174	Comoros	5	14	Eastern Africa	Country	43.34234565	-11.66121732	COM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.89064	1.34486	2.87078	3.55245	2.30648	0.8722	0.76348	0.57451	0.62932	1.61722	8.25366	4.4531	10.3215	7.32316	4.35686	2.40558	6.92658	2.47303	6.87298	6.87298	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	175	Mayotte	5	14	Eastern Africa	Country	45.14015057	-12.82217691	MYT	0	1			[2004, 2005, 2006, 2007, 2008, 2009, 2010]	2004	2010	7	CON_USD	Constant USD	G	Global					4.99853	0.56564	0.39825	5.99675	6.43739	6.29985	1.98739									1.98739	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	178	Congo	5	11	Western Africa	Country	15.22052612	-0.840544119	COG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.21665	1.22901	2.07703	3.9489	6.35578	2.41892	0.33598	3.81804	4.82199	4.44538	23.04317	17.32635	26.90046	17.82131	5.93	9.93882	9.05615	7.84254	11.86395	11.86395	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	18	Southern Africa	4	202	Sub-Saharan Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	18.92447	74.84832	37.91492	36.43816	26.51428	31.25836	50.44276	49.87729	43.87546	65.44927	50.62735	128.61557	96.04104	172.6239	51.82493	108.89664	142.57424	205.93722	223.58714	223.58714	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	180	Democratic Republic of the Congo	5	17	Middle Africa	Country	23.65496507	-2.877154732	COD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	33.76944	41.5488	52.68501	48.92071	66.90027	80.43598	88.5511	115.03623	240.38204	256.39955	277.27334	317.8198	355.93492	404.82543	435.97924	539.48644	438.1567	450.98998	432.338	432.338	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	184	Cook Islands	4	61	Polynesia	Country	-159.7711391	-21.22696458	COK	0	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2002	2018	17	CON_USD	Constant USD	G	Global			0.33499	0.96551	0.4668	0.00311	0.04905	0.08468	0.07614	0.0002	0.0581	0.09174	0.05488	0.12681	0.05327	0.18006	0.09253	0.08592	0.22691	0.22691	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	188	Costa Rica	5	13	Central America	Country	-84.19712782	9.970998683	CRI	1	1			[2000, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	18	CON_USD	Constant USD	G	Global	0.01829		0.26131	0.78296	0.91257	0.97585	3.19015	2.33255	3.85341	1.92211	1.1063	0.46098	0.41046	0.12894	0.39108	0.36386	0.0556	0.30029	2.96811	2.96811	2018		[2000]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	191	Croatia	4	39	Southern Europe	Country	17.95874553	45.45172212	HRV	1	1			[2000, 2001, 2003, 2004, 2005, 2007, 2008, 2009, 2010]	2000	2010	9	CON_USD	Constant USD	G	Global	0.0207	0.43504		0.12274	0.01267	0.01243		0.10934	0.01787	0.06053	0.08349									0.08349	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2003-2005,2007-2010]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	192	Cuba	5	29	Caribbean	Country	-79.54460144	22.10030366	CUB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	4.36191	3.8836	2.56947	3.57152	1.93056	2.5342	2.51935	2.02052	4.9123	3.09289	4.71963	3.67283	2.06855	1.83538	3.12435	2.12473	1.40313	0.76276	1.2686	1.2686	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	199	Least Developed Countries (LDC)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	823.51931	776.12111	649.02275	785.16777	968.7483	1331.44497	1616.20338	1813.27827	2284.9423	2412.25785	2814.55578	2898.28409	3443.94809	4413.89216	4223.1102	4696.39873	4698.2029	4993.12106	4526.45523	4526.45523	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	2	Africa	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	771.75431	957.89229	729.84642	829.80993	1028.93634	1260.90387	1597.37581	1859.40351	2327.04491	2803.46295	2952.62217	3186.38467	3793.81345	4678.20131	4363.3634	5317.98023	5095.04163	5459.65517	4926.6864	4926.6864	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	202	Sub-Saharan Africa	3	2	Africa	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	706.11789	904.96952	664.13093	791.63027	969.36377	1140.82332	1490.66852	1695.63812	2142.48873	2685.53708	2782.86073	3059.00978	3657.00386	4534.98491	4251.75463	5179.05108	4858.89741	5330.76783	4756.7441	4756.7441	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	204	Benin	5	11	Western Africa	Country	2.339933594	9.65401646	BEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	23.13946	6.24506	17.50769	16.12737	21.37275	23.85764	23.51894	29.21286	35.70194	46.26661	53.64806	56.61151	50.93901	62.87878	65.57594	49.95283	50.15612	91.25777	56.90506	56.90506	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	212	Dominica	5	29	Caribbean	Country	-61.3493756	15.43391378	DMA	1	1			[2006, 2007, 2008, 2009, 2010, 2011, 2013, 2015, 2017, 2018]	2006	2018	10	CON_USD	Constant USD	G	Global							0.03993	0.04648	0.01083	0.03006	0.00993	0.06242		0.08945		0.09361		0.03637	0.00068	0.00068	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	214	Dominican Republic	5	29	Caribbean	Country	-70.49847576	18.89832088	DOM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	3.54368	3.29711	7.35413	12.25139	3.59291	12.87467	9.01452	3.84254	5.85535	6.41629	11.15693	7.74675	9.7379	6.3078	6.01588	3.95003	2.69039	4.33339	3.75312	3.75312	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	218	Ecuador	5	5	South America	Country	-78.37005241	-1.447785891	ECU	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.80521	6.13377	2.33008	2.37842	9.95807	16.63406	15.86523	24.76705	20.62401	10.75032	10.88854	9.67125	5.17684	5.51139	6.82986	2.90751	8.45149	8.05858	6.71499	6.71499	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	222	El Salvador	5	13	Central America	Country	-88.86862995	13.73603564	SLV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	12.58457	15.90218	8.54003	8.38148	6.12145	13.9739	13.47776	8.68487	9.12156	7.17292	7.89058	5.26473	4.81042	3.39662	2.57488	3.39967	5.17651	6.68392	7.46071	7.46071	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	223	Eastern Asia (excluding Japan and China)	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	13.0132	2.18341	4.3785	2.75601	3.96348	6.82116	2.26494	14.30802	10.28833	21.93322	38.45459	35.12433	30.01246	34.36206	33.31408	30.10776	45.43055	38.05672	37.13296	37.13296	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	226	Equatorial Guinea	5	17	Middle Africa	Country	10.46535826	1.565792376	GNQ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	5.47862	4.07195	2.66922	3.30827	3.56775	4.72396	9.5869	5.68691	11.45534	6.3216	7.20195	7.34024	2.04254	0.51594	0.67062	1.03959	1.65998	2.61776	1.45085	1.45085	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	231	Ethiopia	5	14	Eastern Africa	Country	39.63505296	8.631223181	ETH	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	20.34368	23.89066	55.70061	114.47336	60.48234	89.80489	179.72932	230.7656	136.87207	259.81581	200.06914	318.96607	336.32331	590.62672	423.90078	404.31399	381.85142	396.99293	461.40105	461.40105	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	232	Eritrea	5	14	Eastern Africa	Country	38.11074289	16.12894644	ERI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	33.29184	3.06336	15.29055	18.41739	11.69051	10.85844	6.03873	13.39772	9.09045	4.52084	28.98568	9.96521	11.53409	20.06468	15.0236	12.51193	12.77337	28.48799	30.19106	30.19106	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	24	Angola	5	17	Middle Africa	Country	17.57817062	-12.33724746	AGO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	21.50417	64.87604	18.78893	24.43797	11.15257	42.68387	25.80942	47.93373	69.17757	52.02241	57.3866	38.88819	69.63534	69.97177	48.00972	52.96331	47.82864	64.63947	45.38746	45.38746	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	242	Fiji	4	54	Melanesia	Country	177.9660884	-17.83301566	FJI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.47559	0.64018	6.56591	4.57151	4.62987	4.20692	0.71237	0.33639	1.30986	1.2289	3.90496	3.29739	9.87398	9.75599	9.78501	15.10278	6.61962	5.41371	7.56376	7.56376	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	262	Djibouti	5	14	Eastern Africa	Country	42.18274707	11.56004161	DJI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.21308	1.32065	1.70918	1.08805	3.25537	5.53039	7.09317	9.79244	8.64349	5.28652	3.9491	2.94692	8.05058	4.31188	4.0302	7.43727	11.85788	8.82298	8.76076	8.76076	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	266	Gabon	5	17	Middle Africa	Country	11.78727747	-0.60687619	GAB	1	1			[2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2001	2018	18	CON_USD	Constant USD	G	Global		0.23945	0.10695	0.93863	3.41539	5.27799	9.0261	4.34604	3.08462	6.50942	2.23311	2.09834	1.69212	2.68242	2.1862	3.56607	4.68228	2.67156	3.73656	3.73656	2018		[2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	268	Georgia	4	145	Western Asia	Country	43.3713615	42.04813028	GEO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	4.707	8.63728	7.67071	4.7197	3.62767	4.96277	3.81251	14.97167	14.25255	10.08237	18.82652	18.10213	6.54175	9.02242	7.46081	4.21866	9.2852	8.3309	3.14329	3.14329	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	270	Gambia	5	11	Western Africa	Country	-15.39944785	13.45295927	GMB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.49131	0.6924	1.54056	2.18672	3.64869	6.18614	4.97677	9.22863	8.08023	8.07649	16.16692	19.2083	22.6027	24.91924	18.95538	20.93873	26.99917	52.37881	47.69996	47.69996	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	275	State of Palestine	4	145	Western Asia	Country	35.25694122	31.94347933	PSE	0	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	30.97439	16.80562	15.52658	39.58655	61.04565	57.51883	65.32969	52.39478	65.46001	66.88603	77.39216	70.84583	77.28301	51.09124	76.64229	101.45159	82.39606	167.49944	104.31031	104.31031	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	28	Antigua and Barbuda	5	29	Caribbean	Country	-61.7999755	17.07761471	ATG	1	1			[2002, 2015, 2017, 2018]	2002	2018	4	CON_USD	Constant USD	G	Global			0.24323													0.00399		0.0428	0.00133	0.00133	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	288	Ghana	5	11	Western Africa	Country	-1.205623522	7.964825185	GHA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	17.43996	32.04303	19.525	29.0022	22.98369	44.58431	37.62809	56.91251	92.95744	116.17736	132.51199	101.60817	173.78961	153.48033	127.0261	153.96892	146.46922	136.27136	164.94714	164.94714	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	29	Caribbean	4	419	Latin America and the Caribbean	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	24.1415	17.84085	14.65391	20.6009	20.62884	24.99498	38.02985	28.40734	43.41499	25.96192	33.39768	88.39574	68.59896	72.79487	54.50403	66.7978	109.96718	109.32905	79.16211	79.16211	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	296	Kiribati	4	57	Micronesia	Country	-157.5643005	1.768837732	KIR	1	1			[2000, 2002, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	16	CON_USD	Constant USD	G	Global	0.09274		0.11562			2.10295	1.22436	0.84482	0.16286	1.57045	0.25542	0.26073	1.75573	1.06597	0.81768	1.11969	1.09207	2.59487	1.5035	1.5035	2018		[2000]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002,2005-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	30	Eastern Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	54.09307	38.0332	52.28576	64.36578	62.14536	60.42138	60.8679	121.69978	71.95657	132.3722	162.13301	111.79274	152.85172	130.9124	109.76639	116.25681	220.27223	187.68967	123.50973	123.50973	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	308	Grenada	5	29	Caribbean	Country	-61.68248568	12.11238395	GRD	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2013, 2015, 2016, 2017]	2003	2017	11	CON_USD	Constant USD	G	Global				0.06906	0.0357	0.00629	0.08266	0.25325	0.14857	0.13169				0.02547		0.01849	0.00525	0.02067		0.02067	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	31	Azerbaijan	4	145	Western Asia	Country	50.01064725	40.39229544	AZE	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	8.62018	1.84246	0.70313	0.99981	1.55473	4.8114	2.69078	8.10262	6.1884	9.08811	9.06045	13.42285	4.27074	10.54137	8.03905	5.57837	4.03877	8.69717	3.15638	3.15638	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	32	Argentina	5	5	South America	Country	-65.14563274	-35.19446255	ARG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.07183	0.20657	1.05743	3.88392	2.21581	2.04838	7.05853	2.83151	31.40046	14.53263	18.05957	6.15933	0.82349	0.73964	0.68967	0.87652	0.59368	1.33868	11.38807	11.38807	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	320	Guatemala	5	13	Central America	Country	-91.2312746	15.00273719	GTM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	4.57875	6.78255	16.56338	22.40054	4.98132	16.64591	23.2286	26.72111	26.17966	22.13748	17.01119	29.66778	21.24956	27.22186	27.0709	49.08194	22.52304	26.15019	19.38695	19.38695	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	324	Guinea	5	11	Western Africa	Country	-11.28173419	11.00210343	GIN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	5.11704	5.7413	6.52756	5.11123	6.68874	8.07921	6.41805	9.12208	9.68442	10.30672	25.12273	7.96292	31.04365	16.86532	99.67672	148.06311	108.17973	82.64895	72.56402	72.56402	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	328	Guyana	5	5	South America	Country	-58.97322037	4.788012784	GUY	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.39635	5.25716	0.06359	0.77755	7.25589	2.77198	1.42121	1.58457	1.32084	3.38574	4.93381	2.41952	2.81482	1.75921	1.16358	1.88803	2.31801	3.70602	2.71455	2.71455	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	332	Haiti	5	29	Caribbean	Country	-72.33640958	18.40426539	HTI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	15.89142	9.88404	2.53242	4.55472	14.56476	8.43891	22.4252	18.49491	29.71634	13.81677	15.9945	75.82256	55.75523	63.94489	43.75614	59.98168	104.4962	100.79775	71.36252	71.36252	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	34	Southern Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	492.58593	285.45214	411.41098	345.38351	397.18463	617.40397	738.94699	793.11001	792.44052	834.51589	1064.01468	824.1231	927.94657	1303.88803	965.33701	1183.52415	1255.41634	1263.51368	1151.24716	1151.24716	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	340	Honduras	5	13	Central America	Country	-86.59974381	14.82243161	HND	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	4.91259	5.9433	9.18182	7.78095	15.72544	20.84705	13.3093	18.25409	27.6736	23.54198	29.91507	24.52664	31.46392	16.15867	27.76718	37.81531	28.21127	11.19602	9.47402	9.47402	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	35	South-Eastern Asia	3	142	Asia	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	205.12801	142.76711	117.71033	151.76235	137.50189	227.53182	316.97126	336.0991	362.0775	395.44779	533.93603	433.956	567.75852	581.47351	521.33992	534.83141	572.69376	838.85317	468.284	468.284	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	356	India	4	34	Southern Asia	Country	79.3608464	22.34642074	IND	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	335.36415	135.19476	296.27634	210.80889	201.1416	295.88514	268.34757	254.9868	218.47881	194.45298	281.38813	309.11975	259.08105	384.09768	246.83453	412.8257	393.11494	296.25261	242.66353	242.66353	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	360	Indonesia	4	35	South-Eastern Asia	Country	113.9174	-0.994582204	IDN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	95.01087	36.149	41.95029	63.62933	48.42213	64.09753	101.18748	108.09807	133.77419	120.65882	115.75991	109.61054	179.21082	151.43624	77.22113	104.06493	139.82528	378.38651	81.25478	81.25478	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	364	Iran (Islamic Republic of)	4	34	Southern Asia	Country	54.19766348	32.74370885	IRN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.55891	0.38906	0.31306	0.30655	0.7089	0.85456	0.78988	0.77659	4.23707	0.13059	5.2708	4.86742	10.61644	5.14828	4.24868	3.66548	2.85279	1.71422	0.31974	0.31974	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	368	Iraq	4	145	Western Asia	Country	43.76606267	33.05013795	IRQ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.30703	4.43001	1.49966	28.40973	75.82978	513.79473	405.86631	223.20465	63.2386	72.57304	52.11692	15.40062	5.31946	23.92183	12.18952	12.39272	5.13108	6.94073	8.23935	8.23935	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	384	Côte d'Ivoire	5	11	Western Africa	Country	-5.552690016	7.62211586	CIV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.73922	2.48558	4.19036	5.55687	15.07815	11.04314	29.54177	19.44345	20.9103	33.73162	73.34621	28.71832	36.48249	61.74748	76.36724	54.40358	106.11579	100.66911	98.2285	98.2285	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	388	Jamaica	5	29	Caribbean	Country	-77.31068409	18.15616857	JAM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.33163	0.40466	0.06014	0.07282	0.2372	0.69011	3.29556	3.3745	2.19523	1.53539	1.45333	0.72611	0.48352	0.14289	0.07472	0.18788	0.10807	2.75711	2.01045	2.01045	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	39	Southern Europe	3	150	Europe	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	34.72872	30.33371	17.9442	24.81284	16.18241	30.36134	41.59552	32.73038	24.73663	8.69177	16.976	16.05993	11.52411	11.30538	16.01577	10.18284	43.36959	66.22374	23.18464	23.18464	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	398	Kazakhstan	4	143	Central Asia	Country	66.65359159	48.01963494	KAZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.87506	3.37055	9.44697	10.78193	6.34194	6.42751	6.72531	5.73452	5.56976	19.60172	28.38009	18.10976	13.29922	7.40025	9.05021	4.48753	6.83479	12.11662	5.93163	5.93163	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	4	Afghanistan	4	34	Southern Asia	Country	66.02688198	33.83160199	AFG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	7.15914	25.37006	20.97795	25.30963	84.48764	156.09319	160.7732	234.61813	197.31613	204.4387	133.15627	144.22365	150.84162	232.09895	249.86725	177.01196	214.69466	210.62161	240.21296	240.21296	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	400	Jordan	4	145	Western Asia	Country	37.13024774	30.65365973	JOR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	8.10331	0.8251	14.35711	1.5375	0.96213	26.74773	19.82291	21.19968	21.73298	26.59723	39.80046	22.17137	31.79224	21.26929	25.92031	39.66272	28.10637	41.06742	27.89824	27.89824	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	404	Kenya	5	14	Eastern Africa	Country	37.86096816	0.534797278	KEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	61.70499	85.21616	41.33241	34.976	35.88358	58.04967	107.35072	67.46742	85.2922	123.90195	188.63465	197.43045	187.84854	199.12501	207.60914	201.08862	171.61841	256.90464	175.50665	175.50665	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	408	Democratic People's Republic of Korea	4	30	Eastern Asia	Country	127.1803633	40.1462645	PRK	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	1.61644	1.98006	3.32127	1.59913	3.07398	3.81844	0.93536	4.41602	3.76939	16.18657	29.22256	16.94159	17.60813	23.81655	26.70806	24.87218	24.28359	25.97172	12.39085	12.39085	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	417	Kyrgyzstan	4	143	Central Asia	Country	74.52324839	41.46204516	KGZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	1.53756	11.70659	6.45674	8.68319	9.36158	12.11248	11.69902	11.70546	14.32549	10.30257	11.35407	20.30376	19.88918	16.52134	24.87155	22.26426	18.27472	25.57082	25.88117	25.88117	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	418	Lao People's Democratic Republic	4	35	South-Eastern Asia	Country	101.9901968	20.27482773	LAO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	40.52054	23.80344	8.83005	10.25871	9.76508	22.69199	18.10902	21.39243	25.83289	18.0567	26.69607	29.41762	35.92853	40.54372	36.27923	32.98092	23.92603	33.62025	29.55037	29.55037	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	419	Latin America and the Caribbean	3	19	Americas	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	149.58971	132.92705	107.04751	140.62514	141.12795	226.80262	249.09422	257.53334	292.49897	259.53413	272.21174	284.35315	255.59981	242.58316	192.10786	239.96211	260.21414	274.72085	221.83688	221.83688	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	422	Lebanon	4	145	Western Asia	Country	35.89391711	33.92152458	LBN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	3.75123	3.02481	1.55392	2.56123	3.57953	17.44171	26.40924	26.17355	18.05548	20.96908	22.23106	19.66057	22.09014	25.0548	44.0609	31.54745	37.65965	41.06978	30.96267	30.96267	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	426	Lesotho	5	18	Southern Africa	Country	28.25362195	-29.58041814	LSO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	3.73329	2.07344	2.94179	4.02778	2.58362	1.68805	0.89619	2.91466	6.23572	3.5553	19.87503	34.6684	29.52483	70.16582	3.63842	2.44587	15.48826	32.5933	25.49682	25.49682	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	430	Liberia	5	11	Western Africa	Country	-9.311879038	6.448381009	LBR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	6.93969	3.4143	4.47921	8.36775	12.41189	10.43069	14.02228	6.61691	28.94997	41.26917	49.09254	54.98154	70.06787	60.74961	122.88919	222.78142	71.17271	67.41903	61.86729	61.86729	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	432	Landlocked developing countries (LLDCs)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	434.26417	451.51529	344.73761	493.74545	550.88521	715.41774	910.91508	1135.2647	1151.0126	1325.97078	1400.88263	1620.16588	1901.5339	2357.98455	2044.49948	2167.84104	2508.57533	2653.56738	2515.63554	2515.63554	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	434	Libya	4	15	Northern Africa	Country	18.0295985	27.04042819	LBY	1	1			[2005, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2005	2018	13	CON_USD	Constant USD	G	Global						0.22611		0.03021	22.89336	16.99506	0.59913	2.88866	0.54252	3.59716	0.09507	0.01172	0.49482	5.9997	5.39632	5.39632	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	450	Madagascar	5	14	Eastern Africa	Country	46.6982339	-19.38514785	MDG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	6.54185	14.03586	15.36598	19.27867	26.50817	47.7755	36.23806	53.03581	56.44594	51.59941	110.32923	61.65934	60.40724	107.32013	85.98937	118.88791	107.5674	85.28249	115.526	115.526	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	454	Malawi	5	14	Eastern Africa	Country	33.4884625	-13.40819859	MWI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	38.31268	16.51746	26.20588	35.41725	31.05686	11.43039	27.11272	45.3184	81.50381	60.76787	61.92917	154.1296	161.26471	167.67735	124.12339	169.84584	241.48802	302.09247	242.70454	242.70454	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	458	Malaysia	4	35	South-Eastern Asia	Country	116.8346314	5.452415309	MYS	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.02043	0.03696	0.4667	0.16015	0.45152	0.34426	0.04253	0.00453	0.03895	0.12337	0.03131	0.32663	0.39186	0.38145	0.39716	0.60908	1.51929	2.66446	2.13208	2.13208	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	462	Maldives	4	34	Southern Asia	Country	73.09672546	-0.614385021	MDV	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.25505	0.20399	0.1817	0.14438	0.37702	0.54964	0.07261	0.21293	0.42105	0.15109	0.26511	0.72175	0.45771	0.36403	0.55509	1.11514	0.58399	0.64635	2.99504	2.99504	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	466	Mali	5	11	Western Africa	Country	-3.522016039	17.35311254	MLI	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	30.16469	33.62843	9.47165	17.1564	23.53418	33.95105	33.21322	38.49003	52.37219	73.95544	104.20607	113.3676	101.9934	111.2588	98.90027	140.03168	143.60119	135.67511	131.21461	131.21461	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	478	Mauritania	5	11	Western Africa	Country	-10.33187259	20.26089546	MRT	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	4.47074	3.45639	4.84175	5.2628	6.29408	3.1364	3.10127	10.16422	9.45873	7.36624	7.85983	5.9275	3.1237	10.85966	13.76225	14.22041	11.56696	16.88227	18.25025	18.25025	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	48	Bahrain	4	145	Western Asia	Country	50.5490754	26.04407747	BHR	1	1			[2002]	2002	2002	1	CON_USD	Constant USD	G	Global			0.00426																	0.00426	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	480	Mauritius	5	14	Eastern Africa	Country	57.568022	-20.28581998	MUS	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	15	CON_USD	Constant USD	G	Global	0.09724	0.04435	0.04483	0.03019	0.02096	0.02056	0.22363					0.22503	0.0762	0.33718	0.08777	0.18726	0.37449	1.16187	0.93455	0.93455	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2006,2011-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	484	Mexico	5	13	Central America	Country	-102.5148166	23.93378032	MEX	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	6.01028	6.92958	4.52863	3.86565	6.34334	6.53034	8.84267	12.21875	3.73153	6.84683	3.6592	3.31712	4.03308	2.99015	1.80935	1.03209	1.72287	4.14961	2.04819	2.04819	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	496	Mongolia	4	30	Eastern Asia	Country	103.0728057	46.83892054	MNG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	11.39676	0.20335	1.05723	1.15688	0.88951	3.00272	1.32958	9.89199	6.51894	5.74665	9.23203	18.18273	12.40433	10.54552	6.60601	5.23559	21.14696	12.08499	24.74211	24.74211	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	498	Republic of Moldova	4	151	Eastern Europe	Country	28.4650624	47.20236795	MDA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	10.38989	1.33394	1.31522	1.04973	1.86093	2.97037	3.53225	6.65092	13.06429	19.22962	17.47993	25.65259	26.37265	24.71397	12.86555	11.90982	14.96484	13.23343	10.07765	10.07765	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	499	Montenegro	4	39	Southern Europe	Country	19.25214024	42.78717043	MNE	1	1			[2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2004	2018	15	CON_USD	Constant USD	G	Global					0.17542	0.28252	2.58629	5.63986	3.47843	0.8448	0.76997	0.17411	0.28394	0.24903	0.19991	0.09382	1.2604	0.04927	0.18124	0.18124	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	5	South America	4	419	Latin America and the Caribbean	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	86.38339	65.11414	46.39391	68.03204	71.34419	118.69151	119.19027	126.08587	146.74809	144.89848	152.88482	115.47661	99.87216	92.46986	53.31777	54.04702	63.89873	77.9827	73.05821	73.05821	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	50	Bangladesh	4	34	Southern Asia	Country	89.17660788	22.86961622	BGD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	96.77646	37.54409	43.60312	38.74137	36.41109	63.58474	151.15028	68.9917	152.70007	150.52239	188.09595	158.52587	132.4238	264.87127	150.08435	230.25251	213.66915	233.8699	221.42178	221.42178	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	500	Montserrat	5	29	Caribbean	Country	-62.19261223	16.73558313	MSR	0	1			[2008, 2009, 2011, 2013, 2014]	2008	2014	5	CON_USD	Constant USD	G	Global									0.17825	0.42966		0.16712		0.20693	0.82612					0.82612	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	504	Morocco	4	15	Northern Africa	Country	-6.281942841	31.8440131	MAR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	3.56791	4.85601	8.41161	8.84586	6.27234	6.21583	2.59252	18.4503	7.31673	6.68484	24.23845	20.41257	4.44913	10.64887	9.83432	4.19762	72.27485	23.35995	19.99727	19.99727	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	508	Mozambique	5	14	Eastern Africa	Country	38.18479941	-14.27963886	MOZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	126.89735	72.72659	65.73665	43.59826	62.15867	54.55557	62.91331	69.08911	93.31875	76.37021	119.90878	125.6633	161.21273	208.98435	252.87749	252.88749	246.06572	239.41049	174.14579	174.14579	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	51	Armenia	4	145	Western Asia	Country	44.93839317	40.29499741	ARM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	7.58574	0.38109	2.88675	2.20893	0.91679	6.89116	13.00082	16.08234	10.15945	13.00361	14.81798	10.8353	9.10071	9.70938	5.8716	5.70046	15.57284	6.45249	9.32747	9.32747	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	512	Oman	4	145	Western Asia	Country	57.87743482	21.98805614	OMN	1	1			[2000, 2001, 2002, 2003]	2000	2003	4	CON_USD	Constant USD	G	Global	0.39211	0.24834	0.26715	0.26686																0.26686	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2003]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	514	Developed Regions	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	45.11861	31.66764	19.25942	25.86257	18.04334	42.79939	60.84901	53.68836	53.67117	36.97621	49.27618	65.98455	64.87217	63.18509	66.92937	77.36639	133.22987	117.95534	86.25092	86.25092	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	515	Developing Regions	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2262.30003	2044.37064	2214.21331	2303.96773	2759.83653	4039.54846	4568.05996	5541.24577	5523.36439	6390.0719	7038.30191	6678.12224	7500.05077	9139.8213	8314.8556	9851.26776	9923.52938	11590.99223	9902.85363	9902.85363	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	516	Namibia	5	18	Southern Africa	Country	17.21907885	-22.13817068	NAM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	1.19897	0.26749	0.77139	1.16618	2.16618	2.98149	7.57372	10.6005	3.84988	13.37018	4.82284	5.25214	6.30063	8.1559	9.30747	4.26264	10.42494	14.16673	17.06927	17.06927	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	52	Barbados	5	29	Caribbean	Country	-59.5346489	13.13648273	BRB	1	1			[2004, 2006, 2009, 2010]	2004	2010	4	CON_USD	Constant USD	G	Global					0.00482		0.00857			0.03264	0.00993									0.00993	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	520	Nauru	4	57	Micronesia	Country	166.92313	-0.528742623	NRU	1	1			[2005, 2006, 2007, 2008, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2005	2018	12	CON_USD	Constant USD	G	Global						0.23504	0.19595	0.70673	0.16294			0.01564	0.19433	0.22179	0.08632	8.01711	0.52219	0.44967	0.40978	0.40978	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	524	Nepal	4	34	Southern Asia	Country	83.94678863	28.25866332	NPL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	17.16501	39.7095	22.28263	20.93818	16.34356	20.66811	25.04582	40.26797	42.65092	38.51642	80.1602	57.64695	56.90202	79.24889	111.28459	103.98951	75.73755	63.83309	55.41997	55.41997	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	54	Melanesia	3	9	Oceania	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	132.65794	3.90343	76.67915	58.81892	51.9918	45.10431	27.58354	37.24126	60.12123	79.96965	43.62083	59.16445	60.93192	80.04835	43.8941	107.03862	50.33614	59.88922	71.42793	71.42793	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	548	Vanuatu	4	54	Melanesia	Country	167.0679779	-15.34445547	VUT	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.53521	0.31396	0.37103	0.92042	0.72331	0.78614	0.50393	0.97875	3.31645	5.2684	3.96104	6.44335	5.3331	8.31257	5.26012	5.86614	2.03855	4.14541	4.6365	4.6365	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	558	Nicaragua	5	13	Central America	Country	-85.03060315	12.84210839	NIC	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	8.46938	14.23378	6.72544	8.22088	14.57823	23.6257	29.13835	34.33525	31.08629	26.13566	25.21423	16.50226	24.29979	26.03563	22.37527	20.65379	23.3982	31.90388	19.22593	19.22593	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	562	Niger	5	11	Western Africa	Country	9.400167877	17.42143036	NER	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.21284	2.29822	6.2291	11.59405	17.79551	24.5339	45.45991	29.97051	52.78697	52.89424	66.22378	47.38008	32.21354	56.43344	86.89027	71.15535	76.65481	90.5801	104.01427	104.01427	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	566	Nigeria	5	11	Western Africa	Country	8.097363256	9.585789025	NGA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	19.47933	126.11733	56.31385	59.52908	99.2516	78.77166	127.45147	180.7836	233.65844	487.336	187.71218	258.78609	335.16883	540.7767	454.3084	733.0909	564.2064	698.19482	475.46366	475.46366	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	57	Micronesia	3	9	Oceania	Region								[2000, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	18	CON_USD	Constant USD	G	Global	0.09274		0.11562	8.37347	1.02977	3.55027	2.39529	1.73551	1.26267	2.53663	0.86325	0.85208	2.39314	2.43386	1.50614	9.91433	2.21109	3.88906	2.59205	2.59205	2018		[2000]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	570	Niue	4	61	Polynesia	Country	-169.8601693	-19.05000475	NIU	0	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2002	2018	17	CON_USD	Constant USD	G	Global			0.21641	0.00049	0.13073	5.40838	0.95992	0.40077	0.48686	0.26155	0.20691	0.03218	0.01382	0.16626	0.01376	0.02882	0.01033	0.05005	0.01581	0.01581	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	583	Micronesia (Federated States of)	4	57	Micronesia	Country	158.225216	6.880670092	FSM	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2003	2018	16	CON_USD	Constant USD	G	Global				4.98039	0.02709	0.05465	0.07275	0.06748	0.04868	0.06637	0.23824	0.19421	0.1887	0.58477	0.41209	0.39077	0.39198	0.55432	0.36594	0.36594	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	584	Marshall Islands	4	57	Micronesia	Country	171.0839119	7.110213497	MHL	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2003	2018	16	CON_USD	Constant USD	G	Global				2.44264	0.10715	0.23235	0.1072	0.09015	0.12004	0.08618	0.11046	0.33194	0.20737	0.34466	0.16429	0.22429	0.1467	0.20592	0.22441	0.22441	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	585	Palau	4	57	Micronesia	Country	134.5733878	7.502307591	PLW	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2003	2018	16	CON_USD	Constant USD	G	Global				0.95044	0.89553	0.92529	0.79503	0.02633	0.76815	0.81363	0.25914	0.04956	0.047	0.21667	0.02576	0.16247	0.05816	0.08428	0.08843	0.08843	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	586	Pakistan	4	34	Southern Asia	Country	68.80479684	29.36491634	PAK	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	25.03583	30.984	24.33188	37.27295	44.16027	62.44076	118.41196	179.1039	156.27861	223.71837	343.73734	130.84368	294.72537	317.91851	175.82965	214.92099	331.0497	402.76173	359.45214	359.45214	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	591	Panama	5	13	Central America	Country	-81.26616623	8.450965746	PAN	1	1			[2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2001	2018	18	CON_USD	Constant USD	G	Global		0.18068	0.03897	0.52806	0.48948	0.46585	0.63478	0.48031	0.68201	0.90618	0.30214	0.1799	0.35796	0.68833	1.06652	3.40832	1.95981	4.92246	4.65502	4.65502	2018		[2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	598	Papua New Guinea	4	54	Melanesia	Country	145.8587761	-6.756057077	PNG	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	122.28815	1.04176	69.4168	53.07477	45.82463	38.76277	26.21258	34.83207	39.04173	55.31797	26.53454	43.67684	40.62413	37.39584	23.96974	67.88883	24.92388	45.80901	52.40801	52.40801	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	600	Paraguay	5	5	South America	Country	-60.54854225	-21.70216237	PRY	1	1			[2000, 2001, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	18	CON_USD	Constant USD	G	Global	0.3333	0.61068		0.18867	0.72649	1.48569	1.73111	8.35389	7.78293	4.86111	11.55682	4.49781	6.77803	4.92477	3.63904	5.94798	6.42024	7.97734	11.08304	11.08304	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2003-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	604	Peru	5	5	South America	Country	-71.82093277	-13.58939705	PER	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	13.59129	10.89669	18.67071	15.61037	14.87236	46.99835	29.73907	22.90079	32.41722	61.55461	32.75406	22.16444	40.69591	34.87171	10.84698	10.09553	16.07698	12.76619	11.61549	11.61549	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	608	Philippines	4	35	South-Eastern Asia	Country	120.8601418	14.16591706	PHL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	18.71605	17.67732	16.69951	16.63224	21.51731	12.26875	25.84582	52.6751	28.72019	41.49575	84.26619	62.80554	33.40667	40.63188	57.26231	102.44721	75.52162	78.41579	65.01441	65.01441	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	61	Polynesia	3	9	Oceania	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.00099	5.81307	5.13479	3.73946	1.31624	13.61989	4.0873	3.67552	2.01585	1.06594	6.78864	13.03798	6.54238	8.14277	1.76577	7.90407	10.38514	9.05076	6.88303	6.88303	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	624	Guinea-Bissau	5	11	Western Africa	Country	-14.40182514	12.11760394	GNB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.49599	5.45317	2.31067	1.34722	3.29182	3.79707	3.16222	6.08481	6.03853	5.56317	20.67535	6.41144	15.22222	35.71925	11.41495	19.66318	21.76816	23.35154	25.35692	25.35692	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	626	Timor-Leste	4	35	South-Eastern Asia	Country	125.9451052	-8.797497247	TLS	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.3864	6.69061	1.16832	2.47741	3.44622	8.22177	18.38219	12.2048	10.17393	10.12119	8.28999	3.33469	14.32552	7.2218	11.77156	14.76527	16.48184	12.42101	11.32121	11.32121	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	64	Bhutan	4	34	Southern Asia	Country	90.45098484	27.39598568	BTN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	3.83485	0.89495	0.57746	4.93393	2.97391	5.81813	3.79292	2.15551	2.28982	2.00442	1.07192	2.05385	2.16633	1.95055	3.2258	4.22382	2.17083	2.68127	1.4521	1.4521	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	646	Rwanda	5	14	Eastern Africa	Country	29.92310194	-1.999842114	RWA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	13.95539	9.13475	23.11286	12.37477	26.65522	32.18576	62.91691	40.3163	83.13423	91.66292	73.1246	75.82209	78.45018	86.40635	107.35301	88.14662	84.46497	91.07183	61.2117	61.2117	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	659	Saint Kitts and Nevis	5	29	Caribbean	Country	-62.76628613	17.33994219	KNA	1	1			[2002, 2003, 2009]	2002	2009	3	CON_USD	Constant USD	G	Global			1.85759	0.02578						0.02636										0.02636	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	660	Anguilla	5	29	Caribbean	Country	-63.05651612	18.21525315	AIA	0	1			[2000, 2001, 2002, 2013]	2000	2013	4	CON_USD	Constant USD	G	Global	0.01286	0.26718	0.03133											0.00137						0.00137	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002,2013]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	662	Saint Lucia	5	29	Caribbean	Country	-60.96529553	13.89405601	LCA	1	1			[2003, 2004, 2005, 2006, 2007, 2008, 2009, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2003	2018	15	CON_USD	Constant USD	G	Global				0.05151	0.08515	0.09263	0.2893	0.11902	0.16385	0.12727		0.19796	0.04319	0.06866	0.49779	0.20443	1.22127	0.5735	0.38796	0.38796	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	670	Saint Vincent and the Grenadines	5	29	Caribbean	Country	-61.19024321	13.24627968	VCT	1	1			[2001, 2004, 2005, 2006, 2007, 2008, 2009, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2001	2018	14	CON_USD	Constant USD	G	Global		0.10132			0.00482	0.09691	0.27297	0.25325	0.23427	0.29451			0.51057	0.17205	0.20904	0.23297	0.04287	0.00472	0.37746	0.37746	2018		[2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2004-2009,2012-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	678	Sao Tome and Principe	5	17	Middle Africa	Country	6.609772265	0.241554875	STP	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.21949	0.48076	0.23958	0.19605	0.21206	2.10722	2.76086	2.14546	4.83696	2.44175	3.43052	5.40553	2.88843	5.72355	5.07261	3.9164	5.32098	6.50389	2.93356	2.93356	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	68	Bolivia (Plurinational State of)	5	5	South America	Country	-64.66224284	-16.71273412	BOL	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	64.36499	35.69086	19.01937	40.40607	20.40715	29.89458	48.5657	46.65297	30.95346	22.21959	30.45818	31.87043	29.55994	21.26708	16.95714	22.50742	19.74976	22.15645	14.98874	14.98874	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	682	Saudi Arabia	4	145	Western Asia	Country	44.54763347	24.12594211	SAU	1	1			[2001]	2001	2001	1	CON_USD	Constant USD	G	Global		0.01362																		0.01362	2018		Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	686	Senegal	5	11	Western Africa	Country	-14.46636926	14.35920905	SEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	5.52754	25.78245	20.53674	26.47102	47.21364	41.25616	85.59213	34.65606	58.69583	63.36211	56.31758	55.42292	97.81535	75.25006	113.15254	88.4494	87.31563	74.23333	88.57513	88.57513	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	688	Serbia	4	39	Southern Europe	Country	20.805876	44.03145697	SRB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	15.51741	11.84202	5.02191	4.35496	2.43921	9.48363	7.77775	4.63307	7.14211	1.03417	2.64036	1.93921	1.43589	1.75648	2.05202	1.25928	0.89779	26.67889	0.51542	0.51542	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	690	Seychelles	5	14	Eastern Africa	Country	55.46561591	-4.678053059	SYC	1	1			[2004, 2005, 2007, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2004	2017	10	CON_USD	Constant USD	G	Global					0.79833	0.78319		0.00502				0.10295	0.19702	0.25454	0.16045	0.16017	3.41388	0.01839		0.01839	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	694	Sierra Leone	5	11	Western Africa	Country	-11.78306584	8.568604164	SLE	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.91256	2.3104	3.05748	7.67151	9.26912	13.14863	19.89453	20.52479	23.72165	25.68778	34.22846	26.23627	24.59123	30.80671	105.71341	148.81897	87.62102	68.54653	70.03498	70.03498	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	70	Bosnia and Herzegovina	4	39	Southern Europe	Country	17.78584332	44.16845548	BIH	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	9.0118	5.34383	5.43791	9.14858	4.57769	4.83248	18.16482	11.42505	6.98618	2.61981	7.80168	6.04845	6.62092	5.5622	10.99833	5.19602	37.98346	36.07086	13.08596	13.08596	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	704	Viet Nam	4	35	South-Eastern Asia	Country	105.802499	10.09643079	VNM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	19.92153	24.38557	28.0612	17.23122	19.94198	44.68509	56.69221	53.74465	61.79883	72.75499	114.55322	99.8866	136.22769	129.13173	92.74121	78.22581	83.5288	91.57653	91.86257	91.86257	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	706	Somalia	5	14	Eastern Africa	Country	46.20367477	4.406485729	SOM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	5.39624	6.26199	6.23509	4.3131	13.88304	12.87525	15.01028	18.88663	18.08763	26.14341	26.09786	26.93536	53.98842	55.99505	65.05911	58.1444	53.84936	57.37837	42.81477	42.81477	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	710	South Africa	5	18	Southern Africa	Country	24.67184355	-29.99957544	ZAF	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	13.44398	71.96983	33.04349	29.82832	20.54574	25.81807	37.82262	32.70112	30.70455	38.34503	16.93014	71.46677	52.24716	83.31234	31.63513	92.40335	92.07843	126.64432	149.92394	149.92394	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	716	Zimbabwe	5	14	Eastern Africa	Country	29.86909584	-19.00075492	ZWE	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	2.55654	3.394	1.28154	9.11046	3.68516	9.4127	8.17432	49.57494	36.24794	65.39151	90.48901	59.21367	117.90384	86.70319	64.88227	126.04799	84.0453	155.0105	112.68171	112.68171	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	72	Botswana	5	18	Southern Africa	Country	23.81380223	-22.18810073	BWA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.41508	0.42522	0.90918	0.29691	0.50342	0.48097	3.33386	2.51612	2.50483	2.12395	4.76328	4.0968	2.9241	3.58342	4.08471	3.71097	5.58369	18.17239	15.29375	15.29375	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	722	Small island developing States (SIDS)	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	164.37556	51.53656	103.99721	100.40038	94.20403	109.04939	99.35105	92.79767	132.74386	138.40774	138.63042	190.30091	192.15011	227.50043	140.02338	243.63687	231.66234	238.47108	223.95707	223.95707	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	728	South Sudan	5	14	Eastern Africa	Country	30.32618773	7.290839152	SSD	1	1			[2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2011	2018	8	CON_USD	Constant USD	G	Global												46.97116	102.59127	85.49095	97.12947	122.76517	64.05213	180.44237	108.73011	108.73011	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	729	Sudan	4	15	Northern Africa	Country	29.95650159	16.02643066	SDN	0	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	12.99074	14.67027	19.2835	16.89311	36.52519	87.34336	55.00295	75.44133	100.51416	74.34322	122.1393	85.79177	116.6949	121.23182	92.30244	115.74741	139.92463	88.86712	113.48273	113.48273	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	740	Suriname	5	5	South America	Country	-55.90626394	4.132603197	SUR	1	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2002	2018	17	CON_USD	Constant USD	G	Global			0.04521	0.33034	0.00972	2.8353	0.9446	1.57556	2.62035	4.98709	5.71758	1.88929	1.27037	1.30182	0.71739	1.87042	0.64903	2.89687	1.74901	1.74901	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	748	Eswatini	5	18	Southern Africa	Country	31.50149288	-26.56471011	SWZ	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.13315	0.11234	0.24907	1.11898	0.71532	0.28978	0.81637	1.14488	0.58048	8.05481	4.23605	13.13146	5.04432	7.40642	3.15919	6.0738	18.99893	14.36048	15.80336	15.80336	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	76	Brazil	5	5	South America	Country	-53.08432878	-10.77668561	BRA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.47186	5.03889	3.29714	2.931	11.13478	11.27847	11.13986	12.60327	13.04099	15.95888	16.26251	20.39664	5.10778	9.29741	2.12009	2.57484	5.7838	6.08388	7.40295	7.40295	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	760	Syrian Arab Republic	4	145	Western Asia	Country	38.50466565	35.01676176	SYR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.72686	2.80785	3.30423	0.5029	4.02919	7.58103	8.50682	9.95236	14.75813	22.37166	14.60533	14.26887	9.05191	5.52458	5.14123	11.69456	14.06065	30.42718	33.47519	33.47519	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	762	Tajikistan	4	143	Central Asia	Country	69.294998	38.43069666	TJK	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	4.8784	1.62275	6.92944	8.92081	13.09479	7.03504	13.80763	14.83934	24.00491	18.11082	29.01731	25.2291	28.16316	24.09319	31.12122	25.39609	27.85127	38.91973	30.29501	30.29501	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	764	Thailand	4	35	South-Eastern Asia	Country	101.0202951	15.13089239	THA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	1.72617	0.08444	0.47367	1.35199	9.75623	16.58492	41.06343	12.14514	19.74471	21.46082	16.47656	34.43324	15.62553	25.35234	31.59617	28.31876	27.13919	39.21885	20.24195	20.24195	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	768	Togo	5	11	Western Africa	Country	0.97835765	8.532096072	TGO	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	16.43767	2.62049	2.25558	3.81792	8.41378	9.82276	5.94173	12.52879	19.6445	15.24199	20.87963	31.86157	7.81424	32.67515	21.17146	17.37981	38.96207	45.97402	23.32871	23.32871	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	772	Tokelau	4	61	Polynesia	Country	-171.8154473	-9.214545558	TKL	0	1			[2003, 2011, 2013, 2014, 2015, 2016, 2017, 2018]	2003	2018	8	CON_USD	Constant USD	G	Global				0.24944								0.02208		0.01332	0.01519	0.02053	0.02949	0.03005	0.02237	0.02237	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	776	Tonga	4	61	Polynesia	Country	-175.1959991	-21.19511329	TON	1	1			[2000, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	17	CON_USD	Constant USD	G	Global	0.00099			0.19502	0.42981	6.98045	1.98881	0.10356	0.14557	0.08456	2.01698	10.99078	4.00982	0.68823	0.63143	1.81862	5.14141	3.93265	2.70577	2.70577	2018		[2000]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2003-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	780	Trinidad and Tobago	5	29	Caribbean	Country	-61.29389504	10.41877263	TTO	1	1			[2001, 2002, 2003, 2004, 2005, 2006, 2007, 2009, 2010]	2001	2010	9	CON_USD	Constant USD	G	Global		0.00294	0.00561	0.0041	0.0795	0.06176	0.08179	0.00288		0.02837	0.05342									0.05342	2018		[2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2007,2009-2010]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	788	Tunisia	4	15	Northern Africa	Country	9.572737411	34.11439971	TUN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.35934	1.37325	0.2256	0.51019	3.72196	3.26136	2.09699	1.47747	1.2691	0.7706	3.78216	2.31615	0.81889	1.20396	1.99914	4.73408	2.36398	5.61158	3.35468	3.35468	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	792	Turkey	4	145	Western Asia	Country	35.42890329	38.9899684	TUR	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.18201	0.43264	0.2089	0.14647	0.29702	0.2728	2.77978	6.91226	2.65299	1.51479	0.94087	0.9815	2.56245	3.27402	2.30189	2.37595	31.12864	176.1584	67.14194	67.14194	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	795	Turkmenistan	4	143	Central Asia	Country	58.9787665	40.0912346	TKM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.93033	1.16453	1.98493	1.96454	1.549	1.90283	1.9975	2.81459	1.47134	2.75434	6.16225	6.14218	2.38241	5.59979	4.57189	2.99745	10.6549	2.82964	2.03322	2.03322	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	796	Turks and Caicos Islands	5	29	Caribbean	Country	-71.745121	21.80780585	TCA	0	1			[2004, 2005]	2004	2005	2	CON_USD	Constant USD	G	Global					0.09342	0.1995														0.1995	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	798	Tuvalu	4	61	Polynesia	Country	178.6679611	-7.460048071	TUV	1	1			[2001, 2002, 2003, 2005, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2001	2018	13	CON_USD	Constant USD	G	Global		5.81307	4.36236	1.61596		0.00311					0.18211	0.19304	0.09895	0.184	0.1092	0.39835	0.70479	0.10333	0.01237	0.01237	2018		[2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2003,2005,2010-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	8	Albania	4	39	Southern Europe	Country	20.06660928	41.13897007	ALB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	9.80101	4.5117	6.00485	10.51398	7.2154	15.60862	9.89403	9.31554	6.22983	3.09319	4.89563	5.09944	3.09615	1.76659	2.1502	2.17577	1.97687	2.34648	8.96276	8.96276	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	800	Uganda	5	14	Eastern Africa	Country	32.39100438	1.279557331	UGA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	52.11517	61.874	29.96497	60.65415	59.93842	75.29006	87.45014	65.31094	83.09915	96.18993	96.23977	103.1215	214.72287	151.40403	197.59383	211.70347	275.77588	230.6943	236.88182	236.88182	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	804	Ukraine	4	151	Eastern Europe	Country	31.40270802	49.00735945	UKR	1	1			[2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2005	2018	14	CON_USD	Constant USD	G	Global						8.42617	14.63929	11.61604	10.23611	8.00745	4.71356	18.94695	20.59176	21.54407	32.34498	53.95472	68.81086	35.32488	49.14533	49.14533	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	807	North Macedonia	4	39	Southern Europe	Country	21.7007909	41.60048068	MKD	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.37781	8.20113	1.47953	0.67259	1.76202	0.14166	3.17265	1.60751	0.8822	1.03927	0.78487	2.79872	0.08721	1.97108	0.61532	1.45795	1.25108	1.07824	0.43926	0.43926	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	818	Egypt	4	15	Northern Africa	Country	29.77468534	26.57438204	EGY	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	48.11863	30.68065	37.06099	11.37826	12.55528	22.36436	46.58598	66.42653	52.258	18.79475	17.44123	13.13356	13.82547	6.24815	7.20495	13.91799	20.30084	4.60619	27.42203	27.42203	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	834	United Republic of Tanzania	5	14	Eastern Africa	Country	34.80521182	-6.265332606	TZA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	22.72779	25.20703	30.81309	29.40788	60.1079	85.23901	101.84336	127.33212	179.34944	198.40919	226.95784	220.96983	260.3615	317.47372	286.55478	330.5482	273.54307	303.38699	238.90832	238.90832	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	84	Belize	5	13	Central America	Country	-88.70199554	17.19965901	BLZ	1	1			[2000, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	18	CON_USD	Constant USD	G	Global	2.49096		0.16011	0.03168	0.0031	0.05154	0.05249	0.01321	0.00784	0.01058	0.83054	0.56139	0.50351	0.69823	1.23089	3.36232	3.30093	2.10275	4.39762	4.39762	2018		[2000]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	854	Burkina Faso	5	11	Western Africa	Country	-1.742843829	12.27491081	BFA	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	5.64933	8.56883	9.31326	12.92724	28.50405	27.63291	35.97037	40.73752	52.27142	67.96385	100.62678	52.03732	78.57333	53.65149	80.83949	113.82898	180.74088	87.15212	113.67296	113.67296	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	858	Uruguay	5	5	South America	Country	-56.01387025	-32.8002838	URY	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017]	2000	2017	18	CON_USD	Constant USD	G	Global	0.05429	0.06683	0.37962	0.1492	0.40949	0.58116	0.33212	1.41258	0.28271	0.36789	2.97194	0.59307	0.6477	0.99498	0.29322	0.22715	0.15896	0.21086		0.21086	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2017]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	860	Uzbekistan	4	143	Central Asia	Country	63.11944558	41.77560518	UZB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	11.26487	9.5887	16.56939	10.52997	23.6652	16.1317	14.43414	15.1248	18.45237	21.50672	20.09271	19.09817	34.51536	26.04299	30.99807	23.76381	59.83992	41.44448	33.86983	33.86983	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	862	Venezuela (Bolivarian Republic of)	5	5	South America	Country	-66.15642084	7.121324748	VEN	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	0.61818	0.05582	0.03324	0.70465	0.31744	0.51333	0.3074	1.55867	1.33914	2.06739	0.91841	0.50558	0.33481	0.37328	0.28513	0.10277	0.08308	0.98162	0.87669	0.87669	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	876	Wallis and Futuna Islands	4	61	Polynesia	Country	-176.2034788	-13.28471201	WLF	0	1			[2005, 2006, 2007, 2008, 2016, 2017, 2018]	2005	2018	7	CON_USD	Constant USD	G	Global						1.02314	1.00139	2.81873	0.43625								2.87519	0.64611	0.23666	0.23666	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	882	Samoa	4	61	Polynesia	Country	-172.4430749	-13.61541469	WSM	1	1			[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2002	2018	17	CON_USD	Constant USD	G	Global			0.22103	0.71304	0.2889	0.20172	0.08813	0.26778	0.87104	0.71962	4.32454	1.70816	2.36491	6.96416	0.94293	5.45768	1.5314	4.20267	3.66315	3.66315	2018		Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	887	Yemen	4	145	Western Asia	Country	45.22389143	15.22242099	YEM	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	31.59432	2.83681	7.29	11.15294	7.86386	21.1788	12.57058	23.87597	26.21295	20.47618	31.79113	33.77276	51.38227	85.50729	106.95628	71.40944	95.65134	297.10251	165.04522	165.04522	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	894	Zambia	5	14	Eastern Africa	Country	27.850329	-14.59701056	ZMB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	34.50942	109.50568	39.30271	48.32802	65.20244	72.99967	64.10424	99.44511	91.19625	81.9685	48.18332	91.4816	125.26096	234.77267	68.14764	151.01075	187.88608	227.22059	196.81289	196.81289	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	9	Oceania	2	1	World	Region								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	132.75166	9.7165	81.92955	70.93185	54.33781	62.27448	34.06613	42.65229	63.39976	83.57222	51.27272	73.05451	69.86744	90.62498	47.16601	124.85702	62.93237	72.82904	80.90301	80.90301	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	90	Solomon Islands	4	54	Melanesia	Country	160.1584117	-9.622391719	SLB	1	1			[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	7.35899	1.90754	0.3254	0.25222	0.81399	1.34848	0.15466	1.09405	16.45319	18.15438	9.22029	5.74688	5.10071	24.58395	4.87923	18.18087	16.75408	4.52109	6.81966	6.81966	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
3	Goal 3	Ensure healthy lives and promote well-being for all at all ages	3.b	Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all	C030b02	3.b.2	Total net official development assistance to medical research and basic health sectors	2020.Q2.G.03	['means of implementation', 'development finance', 'health', 'medical research']	DC_TOF_HLTHL	Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)	921	ODA residual	1			Group								[2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018]	2000	2018	19	CON_USD	Constant USD	G	Global	413.88347	303.96292	609.06118	558.84759	698.90371	864.80873	891.84944	1603.22333	1233.56712	1540.65175	1554.46427	1393.31584	1328.93954	1767.83803	1575.95781	1953.47323	1867.34619	2463.07405	2374.32663	2374.32663	2018		[2000-2001]: Commitments | Based on OECD, CRS databased, 2020 | Constant 2018 USD million // [2002-2018]: Gross disbursements | Based on OECD, CRS databased, 2020 | Constant 2018 USD million	The Organisation for Economic Co-operation and Development (OECD).		C: Country data
